#tech-funding

#tech-funding

Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.

The real breakthrough isn't just using better AI models, but in giving those models deep, structured understanding of how an organization functions, making reliable detection and automated response possible.

Launching a fund used to be a real test of endurance, with timelines often stretching across many months. The process demanded patience that many ambitious founders found difficult to sustain.

Goldman Sachs' Chief Equity Strategist Peter Oppenheimer has called the recent sell-off in U.S. tech stocks a rare 'buying opportunity,' suggesting that the current market conditions may favor investment in this sector.

Antioch aims to close the sim-to-real gap, addressing the challenge of making virtual environments realistic enough for robots to operate reliably in the physical world.

In March 2026, US startups raised $19.06 billion across 630 deals, a significant decline of 64.4% year-over-year from March 2025's $53.5 billion, which was heavily influenced by OpenAI's $40 billion mega-round.

For decades, personalized financial guidance has been too expensive, too generic, or too hard to access. ChatGPT is finally changing that.

"We were considering multiple forms of capital when we started. It just felt like the opportunity is so large that venture capital gives us the opportunity to take those risks upfront and have the possibility to generate an outsized return."

Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.